AFAnders Franco-Cereceda

Anders Franco-Cereceda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anders Franco-Cereceda has a total of 237 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Functional fine-mapping of the 9p21.3 cardiovascular disease locus implicates the lncRNA MIR31HG as an effector transcript in endothelial cells

    by Artemy Zhigulev, Flore-Anne Poujade, Nikita Gryzunov, Andrey Buyan, Haonan Li, Otto Bergman, Minghui Liu, Sailendra Pradhananga, Anders Franco-Cereceda, Peter Swoboda, et al.

    BACKGROUND: The chromosome 9p21.3 locus is among the strongest genetic risk loci for cardiovascular disease (CVD), yet the regulatory mechanisms underlying this association remain poorly understood. Previous vascular disease studies focused predominantly on the role of this locus in smooth muscle cell (SMC) dysfunction, whereas its potential role in endothelial cells (ECs) remains less well characterized. Here, we sought to identify candidate regulatory variants at 9p21.3, their distal target genes, and effector transcripts that contribute to CVD-related phenotypes in ECs. METHODS: Promoter capture Hi-C was used to map chromatin interactions at 9p21.3 in primary human ascending aortic SMCs (n=6), supplementing the previously obtained ECs (n=16) dataset. To support the regulatory relevance of these interactions, expression quantitative trait locus analysis was performed in 136 vascular biopsies. Variant effects were prioritized in silico using AlphaGenome. The regulatory activity of the prioritized region was validated using CRISPR activation. RESULTS: Chromatin interaction mapping identified a complex regulatory architecture at the 9p21.3 locus involving 19 putative regulatory elements and 15 genes across ECs and SMCs. MIR31HG showed the most recurrent distal promoter connectivity with the 9p21.3 region. Consistent with the chromatin interaction map, expression of MIR31HG transcripts was associated with genetic variation at the 9p21.3 locus. In ECs, the lncRNA MIR31HG, but not miR-31, was responsive to hemodynamic flow. Depletion of MIR31HG in ECs was associated with endothelial activation. Epigenetic tracks and deep learning predictions highlighted an active enhancer element at 9p21.3, which was subsequently validated by CRISPR activation and increased MIR31HG expression, confirming its capacity to regulate MIR31HG over a large genomic distance of approximately 538 kb. CONCLUSIONS: Altogether, these data implicate lncRNA MIR31HG as a likely effector of the 9p21.3 CVD locus, linking the cis-regulatory element and heritable genetic variation in the respective region to endothelial activation through long-range enhancer regulation. Clinical Perspective: What Is New? Promoter capture Hi-C in primary human vascular cells identified recurrent long-range interactions between the 9p21.3 cardiovascular disease locus and the MIR31HG promoter, extending the regulatory landscape beyond the nearest genes. Expression of MIR31HG transcripts was associated with 9p21.3 genetic variation in vascular tissue; the lncRNA MIR31HG was responsive to hemodynamic flow in endothelial cells and influenced the endothelial activation transcriptional programs upon depletion. Integrated sequence-based, epigenomic, genetic, and CRISPR activation analyses nominated the 9p21.3 enhancer as a regulator of MIR31HG in endothelial cells. What Are the Clinical Implications? The findings suggest that the cardiovascular disease associations of 9p21.3 may involve stronger than previously anticipated endothelial regulatory mechanisms in addition to characterized effects in other vascular cell types. lncRNA MIR31HG provides a molecular link between noncoding genetic variation at 9p21.3 and endothelial cell-state regulation relevant to vascular disease.

  • Open Access

    Impact of Preoperative COVID-19 Infection on Myocardial Injury and Outcomes After Aortic Valve Surgery in the Pre-Vaccination Era

    by Mohammed Hashem, Payam Haftbaradaran Esfahan, Daniel Daher, Anders Franco-Cereceda, Magnus Bäck

    Objectives: To determine whether preoperative COVID-19 infection before vaccine introduction was associated with postoperative myocardial injury and long-term adverse outcomes after surgical aortic valve replacement. Methods: This prospective cohort study included patients undergoing surgical aortic valve replacement between July 2020 and May 2021. Preoperative COVID-19 infection status was determined by antibody testing. Baseline data were collected, and outcomes were identified through structured medical-record review. The primary endpoint was a composite of major adverse cardiovascular events and all-cause mortality. Kaplan–Meier curves, Cox proportional hazards regression and logistic regression were used. Models were adjusted for age, preoperative heart failure, hypertension, diabetes, prior percutaneous coronary intervention and concomitant aneurysm surgery. Postoperative creatine kinase myocardial band within 24 h was analysed in relation to infection status, extracorporeal circulation time and aortic cross-clamp time. Results: Ninety-nine patients were included; 15 had prior COVID-19 infection and 84 did not. Median follow-up was 3.4 years. The primary endpoint occurred in 2/15 patients with prior COVID-19 infection (13.3%) and 4/84 patients without prior COVID-19 infection (4.7%; P = .5). Adjusted estimates were numerically higher but non-significant for patients with prior COVID-19 infection (hazard ratio 6.6, 95% confidence interval 0.3-109, P = .1; odds ratio 6.6, 95% confidence interval 0.7-65, P = .3), whereas age was associated with outcome (hazard ratio 1.1/year, 95% confidence interval 1.0-1.4, P = .03). Creatine kinase myocardial band was associated with extracorporeal circulation time (coefficient 0.003/min, 95% confidence interval 0.002-0.004, P < .001) and aortic cross-clamp time (coefficient 0.004/min, 95% confidence interval 0.003-0.005, P < .001), without significant interaction with infection. Conclusions: Preoperative COVID-19 infection was not significantly associated with long-term outcome, whereas age was associated with adverse outcome. CK-MB appeared more closely linked to operative ischaemic burden than prior COVID-19 infection.

  • Open Access

    Sex Differences in Clinical Outcomes and Loss of Life Expectancy After Aortic Valve Surgery for Infective Endocarditis: A SWEDEHEART Study

    by Lisa Bearpark, Michael Dismorr, Anders Franco‐Cereceda, Ulrik Sartipy, Natalie Glaser

    Background: Female patients with infective endocarditis (IE) are referred to surgery less often than male patients, and research on sex differences after IE surgery is inconclusive. Understanding the impact of sex can help clinicians optimize patient care. Therefore, we investigated sex‐based differences in loss of life expectancy and net survival after aortic valve surgery for IE. Methods: We conducted a population‐based, observational cohort study, including all patients undergoing aortic valve surgery for IE in Sweden from 1997 to 2022. Data came from national registers, including SWEDEHEART (Swedish Web‐System for Enhancement and Development of Evidence‐Based Care in Heart‐Disease Evaluated According to Recommended Therapies). Loss of life expectancy and net survival were calculated based on population data from the Human Mortality Database. Flexible parametric models were used to assess net survival. Results: A total of 2585 patients underwent aortic valve surgery for IE; 19% were female. Women were older than men (median age 66 versus 63) and had more concomitant valve surgery and comorbidities, as well as lower socioeconomic status. During a mean follow‐up of 7 years, 245 female patients (49%) versus 857 male patients (41%) died. Loss of life expectancy was accentuated in younger patients, ranging from 15.5 years (95% CI, 9.0–21.9) in a 50‐year‐old female to 2.1 years (95% CI, 0.95–3.2) in an 80‐year‐old male. After regression standardization, women had higher net survival compared with men. Conclusions: After aortic valve surgery for IE, net survival was higher among female patients after accounting for baseline differences, and loss of life expectancy was considerable for both female and male patients, particularly in younger patients. Focus on early diagnosis, as well as optimized pre‐ and postoperative care, is essential in patients with IE.

  • Open Access

    Changes in Cardiac-Arterial Coupling After Cardiac Surgery for Aortic Valve Disease

    by Anna Giani, Oscar Plunde, Cristina Oliveira da Silva, Claudia Martins Sequeira, Kambiz Shahgaldi, Luis Miguel Cardoso Dos Santos, Francesco Fantin, Mauro Zamboni, Aristomenis Manouras, Anders Franco-Cereceda, et al.

    Background:Aortic valve disease affects vascular and cardiac remodeling and function, with changes observed after cardiac surgery. Ventricular-arterial coupling (VAC), which reflects the interaction between the left ventricle and the arterial system, may be altered by aortic valve replacement (AVR). Therefore, this study aimed to determine changes in VAC and atrial-arterial coupling (AAC) in patients with aortic valve disease before and after AVR.Methods:A total of 41 patients (median age 67 years, interquartile range (IQR) 62–71) undergoing AVR, including 24 (58.5%) with aortic stenosis (AS), were evaluated before and early (3 days) after cardiac surgery. Left atrial reservoir strain (LARS) and left ventricular (LV) global longitudinal strain (GLS) were assessed by echocardiography. Carotid–femoral pulse wave velocity (cfPWV), brachial-ankle-PWV (baPWV), and cardio-ankle vascular index (CAVI) were measured. VAC and AAC were defined as ratios of arterial stiffness to cardiac strain (CAVI/GLS, CAVI/LARS, baPWV/GLS, baPWV/LARS, cfPWV/GLS, cfPWV/LARS).Results:Atrial and ventricular strain and arterial stiffness significantly worsened after surgery. Ventricular-arterial uncoupling was reflected by a substantial increase in arterial stiffness to LV strain ratios (p < 0.001 for each). Moreover, AAC, measured as CAVI/LARS or PWV/LARS, significantly increased after surgery, with p < 0.001 for CAVI/LARS and baPWV/GLS, and p = 0.035 for cfPWV/LARS.Conclusions:Worsened ventricular-arterial uncoupling can be detected early after cardiac surgery using novel measures of VAC, including ratios of peripheral arterial stiffness to cardiac deformation. This study extends these findings by demonstrating atrial-arterial uncoupling, suggesting a generalized cardiac-arterial uncoupling after valve surgery.

  • Open Access

    Rare regulatory mutations disrupt mesenchymal molecular programs driving endocardial cushion formation in bicuspid aortic valve

    by Artemy Zhigulev, Andrey Buyan, Enikő Lázár, Nikita Gryzunov, Karin Lång, Raphaël Mauron, Vladimir Nozdrin, Rapolas Spalinskas, Sailendra Pradhananga, Madeleine Petersson Sjögren, et al.

    Bicuspid aortic valve, a prevalent congenital malformation, predisposes individuals to severe complications. Although the condition exhibits substantial heritability, known protein-coding and common regulatory mutations explain a minority of cases. To assess the contribution of rare regulatory variants, here we integrate high-resolution three-dimensional genome organization profiling with matched whole-genome sequencing from eight individuals with bicuspid aortic valves and eight with standard tricuspid aortic valves. In bicuspid aortic valve patients, mutation-driven chromatin rewiring affected 1.8-fold more valve development genes than in healthy individuals. Genome-wide in silico analyses show that rare regulatory mutations disrupt the transcriptomes of mesenchymal cell populations necessary for endocardial cushion formation. We identify 198 candidate genes associated with bicuspid aortic valve, revealing pronounced heterogeneity and complex interplay between coding and regulatory mutations. Collectively, our findings establish rare regulatory mutations as contributors to the heritability of bicuspid aortic valve and underscore the need to elucidate their mechanistic roles in disease pathogenesis.


  • Top Cited Papers

    Genome and Transcriptome-Wide Analyses Identify Multiple Candidate Genes and a Significant Polygenic Contribution in Bicuspid Aortic Valve

    by Sébastien Thériault, Jacob A. Holdcraft, Dinara Sharipova, Adèle Faucherre, Radoslaw M. Debiec, Gina M. Peloso, Baravan Al-Kassou, Sary Aranki, Elena Ashikhmina Swan, Andrea Ballotta, et al.

    BACKGROUND: Bicuspid aortic valve (BAV) is a frequent congenital heart defect with a high heritability. Despite this, only a limited number of genes have been associated with the disease, and the molecular mechanisms remain unexplained in most cases. This study aimed to further understand the genetic architecture of BAV. METHODS: A genome-wide association study meta-analysis including 9631 cases among 65 677 participants was performed. Genes were prioritized using transcriptomic analyses based on RNA sequencing in relevant tissues, including human fetal and adult aortic valves. The impact of the knockdown or knockout of 4 candidate genes on cardiac development was verified in zebrafish. A polygenic risk score was developed, its association with BAV was evaluated in an independent cohort, and its association with a wide range of phenotypes (n=976) was evaluated in UK Biobank (n=355 618 individuals). RESULTS: Thirty-six genomic loci were identified, including 32 that were not described previously. Among the prioritized genes, KANK2 and ERBB4 were identified as potentially causal through transcriptomic analyses, colocalization, and Mendelian randomization based on gene expression in human aortic valves (n=484), whereas PRDM6 and STRN were prioritized using similar analyses from aortic (n=326) and left ventricular tissues (n=326), respectively. Targeting 4 candidate genes ( WNT4 , LEF1 , STRN , and KANK2 ) in zebrafish led to disruption in cardiac development. A polygenic risk score was associated with an odds ratio of 2.07 (95% CI, 1.90–2.25; P =5.43×10 -62 ) per SD for BAV and significantly associated with thoracic aortic aneurysm and atrial fibrillation in UK Biobank. CONCLUSIONS: This study supports a significant polygenic contribution to BAV, where the combination of multiple common variants in genes involved in heart morphogenesis disrupts aortic valve development.


  • Open Access

    Combining Ascending Aortic Diameter and Length and Their Growth Rates Improves the Prediction of Type A Aortic Dissection

    by Iida-Mari Kotanen, Tuomas Selander, Christian Olsson, Anders Franco-Cereceda, David Marlevi, Petri Saari, Tarmo Korpela, Saara Sillanmäki, Marja Hedman

    Objectives: The majority of acute type A aortic dissections (ATAADs) occur at ascending aortic dimensions and growth rates below current preventive surgery thresholds. This study aimed to investigate the risk of ATAAD based on the ascending aortic diameter, length, and their growth rates. Methods: The ascending aortic diameters and lengths were measured using repeated pre-dissection computed tomography and magnetic resonance imaging acquired during follow-up to evaluate their growth patterns and rates prior to the ATAAD onset. Measurements and growth rates were used to develop the risk function for the ATAAD risk assessment. Results: Ascending aortic aneurysm patients (n = 116) were divided into ATAAD (n = 30) and non-ATAAD groups (n = 86). Almost half of the ATAAD patients (46.7%) did not exceed the current preventive surgery thresholds based on the dimensions. A diameter growth rate of 3 mm/year was extremely rare (2.6%). The risk function was introduced in this study, and it could be used to predict the 5-year risk of ATAAD with excellent confidence (area under the curve [AUC] value of 0.83 (95% CI [0.54-0.98])). Conclusions: The combination of ascending aortic diameter and length and their growth rates offers a valuable tool for assessing the risk of an ATAAD. Almost half of the ATAAD patients fall below the established thresholds when assessed using only ascending aortic dimensions. These findings suggest that preventive surgery thresholds may benefit from including all four parameters: ascending aortic diameter and length and their growth rates. Clinical registration number: DilAo-Trial ClinicalTrials.gov ID 5063566


  • Long-Term Durability of the Sorin Soprano Aortic Bioprosthetic Valve—A Swedish Nationwide Study

    by Gustav Hökfelt, Allan Clarelin, Magnus Höglund, Michael Dismorr, Shahab Nozohoor, Anders Jeppsson, Anna Damlin, Anders Franco-Cereceda, Ulrik Sartipy, Magnus Dalén

    Objectives: Structural valve deterioration is an inherent limitation of bioprosthetic valves; however, the time it takes to develop varies depending on the valve model. The Sorin Soprano aortic bioprosthetic valve (Sorin Group/LivaNova, Milan, Italy) lacks reported long-term results. This study aims to establish the long-term durability of this bioprosthetic valve in a nationwide cohort. Methods: All patients who had received the Soprano bioprosthesis during aortic valve replacement in Sweden between 2005 and 2013 were included in the study. Patient characteristics, outcomes, and echocardiographic data were collected using national registries and electronic medical records. Standardized guidelines were used to assess echocardiographic data for the presence of severe structural valve deterioration. Results: A total of 1054 patients (mean age 73.3 years) were included, with 14.0% being ≤65 years at surgery. The Soprano bioprosthesis represented 9.5% of all implanted bioprostheses. During a mean follow-up of 8.6 ± 4.5 years, 206 patients (19.5%) developed severe structural valve deterioration. The cumulative incidence of severe structural valve deterioration at 1, 5, 7, 10, and 15 years was 0.5%, 3.1%, 7.4%, 13.7%, and 22.1%, respectively, in the overall population. The cumulative incidence of structural valve deterioration-related reinterventions at 1, 5, 7, 10, and 15 years was 0%, 0.9%, 3.0%, 7.2%, and 11.5%, respectively. The 30-day mortality rate was 3.8%. Conclusions: The Soprano bioprosthesis demonstrates high long-term rates of severe structural valve deterioration and deterioration-related reinterventions. These findings suggest the need for increased clinical vigilance and for more frequent echocardiographic monitoring in patients having received this bioprosthetic valve.

  • Open Access

    3D immunolabelling of human aortic valves by optimized CUBIC tissue clearing and its application for neural mapping in aortic stenosis

    by Justine Bergeon, David Hupin, Jianjiang Hu, Sylvie Le Guyader, Anders Franco-Cereceda, Magnus Bäck

    Calcific aortic valve stenosis (CAVS) is characterized by significant structural alterations in the aortic valve. However, its neuroanatomical landscape remains poorly understood. In this study, we developed an optimized three-dimensional (3D) imaging approach that combined enhanced Clear, Unobstructed Brain Imaging Cocktails and Computational (CUBIC) tissue clearing and SWITCH-Off/On to visualize the neuronal architecture within calcified human aortic valves derived from patients undergoing aortic valve replacement surgery. Standard CUBIC analysis protocols have shown limited efficacy owing to poor clearing and antibody penetration in mineralized tissues. By integrating SWITCH chemistry before decalcification and refractive index matching, we achieved uniform delipidation, fluorescence preservation, and deep tissue labelling. Light-sheet fluorescence microscopy enabled high-resolution 3D reconstructions with an 80% success rate, revealing heterogeneous and spatially organized neuronal distributions across the aortic valve. This method offers a robust platform for studying valve innervation and its potential role in mechanosensing and disease progression, opening perspectives for neuro-targeted interventions in valvular heart disease.


  • Open Access

    Tricuspid Aortic Valve Regurgitation Associates With Ascending Aortic Aneurysm Through Endothelial Activation and Lipoprotein Infiltration

    by David Freiholtz, Claudia Reyes-Goya, Karin Lång, Otto Bergman, Christian Olsson, Malin Granbom Koski, Michael Dismorr, Cecilia Österholm, Kenneth Caidahl, Anders Franco-Cereceda, et al.

    BACKGROUND: An abnormal accumulation of immune cells and inflammation has been described in ascending aortic aneurysm, but the factor driving disease initiation remains elusive. Interestingly, ascending aortic dilatation often occurs alongside aortic regurgitation but rarely with aortic stenosis. We sought to investigate ascending aortic aneurysm initiation by assessing the relation between aortic regurgitation and vascular activation and inflammation. METHODS: In this prospective cohort study, patients with tricuspid aortic valves undergoing elective open-heart surgery were included. Aortic specimens from organ donors were obtained through the University of Miami Tissue Bank. Spatial transcriptomics measured gene expression in nondilated aortic endothelium, intima, and subintima. Immunohistochemistry determined protein expression. Aortic dimensions were recorded preoperatively and 10 years after surgery using echocardiography. Aortic gene expression affected by physiological blood flow was previously measured in Wistar rats. RESULTS: We show a mesenchymal activation of endothelial cells, possibly mediated by bidirectional flow, in the nondilated ascending aorta of patients with aortic regurgitation, accompanied by intimal infiltration, retention, and oxidation of apoB-containing lipoproteins. We further observed intimal upregulation of genes coding for core proteins of lipoprotein-binding proteoglycans and the OLR1 (oxidized low-density lipoprotein receptor 1), the latter by infiltrating macrophages and in association with progressive inflammation and dilatation. None of the above was observed in patients with aortic stenosis. Notably, surgical replacement of regurgitant valves, but not stenotic valves, mitigated 10-year aortic growth. CONCLUSIONS: Our results highlight a distinct pathological role of aortic regurgitation in ascending aortic aneurysm formation by promoting mesenchymal activation of endothelial cells and lipoprotein-related immune cell infiltration and inflammation in patients with tricuspid aortic valves. We also provide novel insights into the long-term impact of surgical aortic valve replacement on ascending aortic growth and suggest a diagnostic or therapeutic target in oxidized low-density lipoprotein cholesterol.